Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Sharma, Padmanee, Retz, Margitta, Siefker-Radtke, Arlene, Baron, Ari, Necchi, Andrea, Bedke, Jens, Plimack, Elizabeth R, Vaena, Daniel, Grimm, Marc-Oliver, Bracarda, Sergio, Arranz, José Ángel, Pal, Sumanta, Ohyama, Chikara, Saci, Abdel, Qu, Xiaotao, Lambert, Alexandre, Krishnan, Suba, Azrilevich, Alex, Galsky, Matthew D
Published in The lancet oncology (01.03.2017)
Published in The lancet oncology (01.03.2017)
Get full text
Journal Article
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Rini, Brian I, Plimack, Elizabeth R, Stus, Viktor, Gafanov, Rustem, Hawkins, Robert, Nosov, Dmitry, Pouliot, Frédéric, Alekseev, Boris, Soulières, Denis, Melichar, Bohuslav, Vynnychenko, Ihor, Kryzhanivska, Anna, Bondarenko, Igor, Azevedo, Sergio J, Borchiellini, Delphine, Szczylik, Cezary, Markus, Maurice, McDermott, Raymond S, Bedke, Jens, Tartas, Sophie, Chang, Yen-Hwa, Tamada, Satoshi, Shou, Qiong, Perini, Rodolfo F, Chen, Mei, Atkins, Michael B, Powles, Thomas
Published in The New England journal of medicine (21.03.2019)
Published in The New England journal of medicine (21.03.2019)
Get full text
Journal Article
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
Cristescu, Razvan, Mogg, Robin, Ayers, Mark, Albright, Andrew, Murphy, Erin, Yearley, Jennifer, Sher, Xinwei, Liu, Xiao Qiao, Lu, Hongchao, Nebozhyn, Michael, Zhang, Chunsheng, Lunceford, Jared K., Joe, Andrew, Cheng, Jonathan, Webber, Andrea L., Ibrahim, Nageatte, Plimack, Elizabeth R., Ott, Patrick A., Seiwert, Tanguy Y., Ribas, Antoni, McClanahan, Terrill K., Tomassini, Joanne E., Loboda, Andrey, Kaufman, David
Published in Science (American Association for the Advancement of Science) (12.10.2018)
Published in Science (American Association for the Advancement of Science) (12.10.2018)
Get full text
Journal Article
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Kyriakopoulos, Christos E., Chen, Yu-Hui, Carducci, Michael A., Liu, Glenn, Jarrard, David F., Hahn, Noah M., Shevrin, Daniel H., Dreicer, Robert, Hussain, Maha, Eisenberger, Mario, Kohli, Manish, Plimack, Elizabeth R., Vogelzang, Nicholas J., Picus, Joel, Cooney, Matthew M., Garcia, Jorge A., DiPaola, Robert S., Sweeney, Christopher J.
Published in Journal of clinical oncology (10.04.2018)
Published in Journal of clinical oncology (10.04.2018)
Get full text
Journal Article
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Choi, Woonyoung, Porten, Sima, Kim, Seungchan, Willis, Daniel, Plimack, Elizabeth R., Hoffman-Censits, Jean, Roth, Beat, Cheng, Tiewei, Tran, Mai, Lee, I-Ling, Melquist, Jonathan, Bondaruk, Jolanta, Majewski, Tadeusz, Zhang, Shizhen, Pretzsch, Shanna, Baggerly, Keith, Siefker-Radtke, Arlene, Czerniak, Bogdan, Dinney, Colin P.N., McConkey, David J.
Published in Cancer cell (10.02.2014)
Published in Cancer cell (10.02.2014)
Get full text
Journal Article
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial
Powles, Thomas, Plimack, Elizabeth R, Soulières, Denis, Waddell, Tom, Stus, Viktor, Gafanov, Rustem, Nosov, Dmitry, Pouliot, Frédéric, Melichar, Bohuslav, Vynnychenko, Ihor, Azevedo, Sergio J, Borchiellini, Delphine, McDermott, Raymond S, Bedke, Jens, Tamada, Satoshi, Yin, Lina, Chen, Mei, Molife, L Rhoda, Atkins, Michael B, Rini, Brian I
Published in The lancet oncology (01.12.2020)
Published in The lancet oncology (01.12.2020)
Get full text
Journal Article
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
Motzer, Robert J, Rini, Brian I, McDermott, David F, Arén Frontera, Osvaldo, Hammers, Hans J, Carducci, Michael A, Salman, Pamela, Escudier, Bernard, Beuselinck, Benoit, Amin, Asim, Porta, Camillo, George, Saby, Neiman, Victoria, Bracarda, Sergio, Tykodi, Scott S, Barthélémy, Philippe, Leibowitz-Amit, Raya, Plimack, Elizabeth R, Oosting, Sjoukje F, Redman, Bruce, Melichar, Bohuslav, Powles, Thomas, Nathan, Paul, Oudard, Stéphane, Pook, David, Choueiri, Toni K, Donskov, Frede, Grimm, Marc-Oliver, Gurney, Howard, Heng, Daniel Y C, Kollmannsberger, Christian K, Harrison, Michael R, Tomita, Yoshihiko, Duran, Ignacio, Grünwald, Viktor, McHenry, M Brent, Mekan, Sabeen, Tannir, Nizar M
Published in The lancet oncology (01.10.2019)
Published in The lancet oncology (01.10.2019)
Get full text
Journal Article
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
Albiges, Laurence, Tannir, Nizar M., Burotto, Mauricio, McDermott, David, Plimack, Elizabeth R., Barthélémy, Philippe, Porta, Camillo, Powles, Thomas, Donskov, Frede, George, Saby, Kollmannsberger, Christian K., Gurney, Howard, Grimm, Marc-Oliver, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I., Choueiri, Toni K., Saggi, Shruti Shally, McHenry, M. Brent, Motzer, Robert J.
Published in ESMO open (01.01.2020)
Published in ESMO open (01.01.2020)
Get full text
Journal Article
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, Robert J, Escudier, Bernard, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Choueiri, Toni K, Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Tomita, Yoshihiko, Schutz, Fabio A, Kollmannsberger, Christian, Larkin, James, Ravaud, Alain, Simon, Jason S, Xu, Li-An, Waxman, Ian M, Sharma, Padmanee
Published in The New England journal of medicine (05.11.2015)
Published in The New England journal of medicine (05.11.2015)
Get full text
Journal Article
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Motzer, Robert J., Rini, Brian I., McDermott, David F., Redman, Bruce G., Kuzel, Timothy M., Harrison, Michael R., Vaishampayan, Ulka N., Drabkin, Harry A., George, Saby, Logan, Theodore F., Margolin, Kim A., Plimack, Elizabeth R., Lambert, Alexandre M., Waxman, Ian M., Hammers, Hans J.
Published in Journal of clinical oncology (01.05.2015)
Published in Journal of clinical oncology (01.05.2015)
Get full text
Journal Article
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Atkins, Michael B, Plimack, Elizabeth R, Puzanov, Igor, Fishman, Mayer N, McDermott, David F, Cho, Daniel C, Vaishampayan, Ulka, George, Saby, Olencki, Thomas E, Tarazi, Jamal C, Rosbrook, Brad, Fernandez, Kathrine C, Lechuga, Mariajose, Choueiri, Toni K
Published in The lancet oncology (01.03.2018)
Published in The lancet oncology (01.03.2018)
Get full text
Journal Article
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study
Plimack, Elizabeth R, Bellmunt, Joaquim, Gupta, Shilpa, Berger, Raanan, Chow, Laura Q M, Juco, Jonathan, Lunceford, Jared, Saraf, Sanatan, Perini, Rodolfo F, O'Donnell, Peter H
Published in The lancet oncology (01.02.2017)
Published in The lancet oncology (01.02.2017)
Get full text
Journal Article
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study
Plimack, Elizabeth R., Powles, Thomas, Stus, Viktor, Gafanov, Rustem, Nosov, Dmitry, Waddell, Tom, Alekseev, Boris, Pouliot, Frédéric, Melichar, Bohuslav, Soulières, Denis, Borchiellini, Delphine, McDermott, Raymond S., Vynnychenko, Ihor, Chang, Yen-Hwa, Tamada, Satoshi, Atkins, Michael B., Li, Chenxiang, Perini, Rodolfo, Molife, L. Rhoda, Bedke, Jens, Rini, Brian I.
Published in European Urology (01.11.2023)
Published in European Urology (01.11.2023)
Get full text
Journal Article
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
Escudier, Bernard, Sharma, Padmanee, McDermott, David F., George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Procopio, Giuseppe, Plimack, Elizabeth R., Castellano, Daniel, Gurney, Howard, Donskov, Frede, Peltola, Katriina, Wagstaff, John, Gauler, Thomas C., Ueda, Takeshi, Zhao, Huanyu, Waxman, Ian M., Motzer, Robert J.
Published in European urology (01.12.2017)
Published in European urology (01.12.2017)
Get full text
Journal Article
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Choueiri, Toni K., Fishman, Mayer N., Escudier, Bernard, McDermott, David F., Drake, Charles G., Kluger, Harriet, Stadler, Walter M., Perez-Gracia, Jose Luis, McNeel, Douglas G., Curti, Brendan, Harrison, Michael R., Plimack, Elizabeth R., Appleman, Leonard, Fong, Lawrence, Albiges, Laurence, Cohen, Lewis, Young, Tina C., Chasalow, Scott D., Ross-Macdonald, Petra, Srivastava, Shivani, Jure-Kunkel, Maria, Kurland, John F., Simon, Jason S., Sznol, Mario
Published in Clinical cancer research (15.11.2016)
Published in Clinical cancer research (15.11.2016)
Get full text
Journal Article
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial
Rini, Brian I, Dorff, Tanya B, Elson, Paul, Rodriguez, Cristina Suarez, Shepard, Dale, Wood, Laura, Humbert, Jordi, Pyle, Linda, Wong, Yu-Ning, Finke, James H, Rayman, Patricia A, Larkin, James M G, Garcia, Jorge A, Plimack, Elizabeth R
Published in The lancet oncology (01.09.2016)
Published in The lancet oncology (01.09.2016)
Get full text
Journal Article
Emerging role of immunotherapy in urothelial carcinoma—Advanced disease
Zibelman, Matthew, Ramamurthy, Chethan, Plimack, Elizabeth R.
Published in Urologic oncology (01.12.2016)
Published in Urologic oncology (01.12.2016)
Get full text
Journal Article
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial
Motzer, Robert J, Escudier, Bernard, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Powles, Thomas, Donskov, Frede, Plimack, Elizabeth R, Barthélémy, Philippe, Hammers, Hans J, George, Saby, Grünwald, Viktor, Porta, Camillo, Neiman, Victoria, Ravaud, Alain, Choueiri, Toni K, Rini, Brian I, Salman, Pamela, Kollmannsberger, Christian K, Tykodi, Scott S, Grimm, Marc-Oliver, Gurney, Howard, Leibowitz-Amit, Raya, Geertsen, Poul F, Amin, Asim, Tomita, Yoshihiko, McHenry, M Brent, Saggi, Shruti Shally, Tannir, Nizar M
Published in Journal for immunotherapy of cancer (01.07.2020)
Published in Journal for immunotherapy of cancer (01.07.2020)
Get full text
Journal Article
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
Liu, David, Abbosh, Philip, Keliher, Daniel, Reardon, Brendan, Miao, Diana, Mouw, Kent, Weiner-Taylor, Amaro, Wankowicz, Stephanie, Han, Garam, Teo, Min Yuen, Cipolla, Catharine, Kim, Jaegil, Iyer, Gopa, Al-Ahmadie, Hikmat, Dulaimi, Essel, Chen, David Y. T., Alpaugh, R. Katherine, Hoffman-Censits, Jean, Garraway, Levi A., Getz, Gad, Carter, Scott L., Bellmunt, Joaquim, Plimack, Elizabeth R., Rosenberg, Jonathan E., Van Allen, Eliezer M.
Published in Nature communications (19.12.2017)
Published in Nature communications (19.12.2017)
Get full text
Journal Article